Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia

被引:58
作者
Deicken, RF [1 ]
Pegues, M
Amend, D
机构
[1] Dept Vet Affairs Med Ctr, Magnet Resonance Unit, San Francisco, CA 94121 USA
[2] Dept Vet Affairs Med Ctr, Psychiat Serv, San Francisco, CA 94121 USA
[3] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
关键词
brain; hippocampus; limbic system; magnetic resonance spectroscopy; N-acetylaspartate; schizophrenia;
D O I
10.1016/S0920-9964(98)00173-X
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Quantitative magnetic resonance imaging (MRI) can measure total gray matter volume but cannot discriminate between neurons and glia. Proton magnetic resonance spectroscopic imaging (H-1 MRSI) measures N-acetylaspartate (NAA) which is a selective marker of neuronal loss or neuronal dysfunction. The objective of this study was to obtain quantitative measures of hippocampal volume and hippocampal NAA to determine if there was evidence for hippocampal neuronal dysfunction or neuronal loss in schizophrenia. Quantitative MRI and H-1 MRSI was performed on the right and left hippocampal regions in 23 chronic schizophrenic patients and 18 control subjects. Relative to the control group, the patients with schizophrenia demonstrated no change in hippocampal volumes bilaterally, but significantly decreased NAA in the hippocampal regions bilaterally. There was also no correlation between hippocampal volumes and NAA in either the schizophrenics or controls. These findings suggest that: (I) hippocampal NAA may be a more sensitive measure of neuronal loss than Volumetric measurements; and (2) reduced hippocampal NAA may be measuring neuronal dysfunction or damage rather than neuronal loss in this sample of schizophrenics. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 33 条
  • [1] A CLASSIFICATION OF HAND PREFERENCE BY ASSOCIATION ANALYSIS
    ANNETT, M
    [J]. BRITISH JOURNAL OF PSYCHOLOGY, 1970, 61 (03) : 303 - &
  • [2] Bertolino A, 1996, AM J PSYCHIAT, V153, P1554
  • [3] Regionally specific neuronal pathology in untreated patients with schizophrenia: A proton magnetic resonance spectroscopic imaging study
    Bertolino, A
    Callicott, JH
    Elman, I
    Mattay, VS
    Tedeschi, G
    Frank, JA
    Breier, A
    Weinberger, DR
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 (09) : 641 - 648
  • [4] N-ACETYL-L-ASPARTIC ACID - A LITERATURE-REVIEW OF A COMPOUND PROMINENT IN H-1-NMR SPECTROSCOPIC STUDIES OF BRAIN
    BIRKEN, DL
    OLDENDORF, WH
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1989, 13 (01) : 23 - 31
  • [5] HIPPOCAMPUS AMYGDALA VOLUMES AND PSYCHOPATHOLOGY IN CHRONIC-SCHIZOPHRENIA
    BOGERTS, B
    LIEBERMAN, JA
    ASHTARI, M
    BILDER, RM
    DEGREEF, G
    LERNER, G
    JOHNS, C
    MASIAR, S
    [J]. BIOLOGICAL PSYCHIATRY, 1993, 33 (04) : 236 - 246
  • [6] Frontal lobe of children with schizophrenia spectrum disorders: A proton magnetic resonance spectroscopic study
    Brooks, WM
    Hodde-Vargas, J
    Vargas, LA
    Yeo, RA
    Ford, CC
    Hendren, RL
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 (04) : 263 - 269
  • [7] Magnetic resonance spectroscopy and aberrant neurodevelopment
    Buckley, PF
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 : 61S - 61S
  • [8] SERIAL PROTON MAGNETIC-RESONANCE SPECTROSCOPY IN ACUTE MULTIPLE-SCLEROSIS LESIONS
    DAVIE, CA
    HAWKINS, CP
    BARKER, GJ
    BRENNAN, A
    TOFTS, PS
    MILLER, DH
    MCDONALD, WI
    [J]. BRAIN, 1994, 117 : 49 - 58
  • [9] Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy
    Deicken, RF
    Zhou, L
    Schuff, N
    Fein, G
    Weiner, MW
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 (07) : 483 - 488
  • [10] DESTEFANO N, 1995, MAGN RESON MED, V34, P721